Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Lymphedema × pirfenidone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neurofibroma, Plexiform 2 Squamous Cell Carcinoma of Head and Neck 1 Neurofibromatosis 1 1 Neurofibromatoses 1 Nerve Sheath Neoplasms 1 Myofibroma 1 Lymphedema 1 Lung Neoplasms 1 Leiomyoma 1 Colorectal Neoplasms 1 Breast Neoplasms 1 Acute Lung Injury 1

Interventions

Pentoxifylline 2 pycnogenols 1 pirfenidone 1 pazopanib 1 Vitamin E 1 Tocopherols 1 Technetium Tc 99m Sulfur Colloid 1 Surgical Procedures, Operative 1 Standard of Care 1 Sodium Selenite 1 Sodium Chloride 1 Sentinel Lymph Node Biopsy 1 Radiotherapy 1 Pravastatin 1 Physical Therapy Modalities 1 Pharmaceutical Preparations 1 Methylene Blue 1 Mastectomy, Segmental 1 Mastectomy 1 Manual Lymphatic Drainage 1 Lymph Node Excision 1 Lipectomy 1 Ketoprofen 1 Indocyanine Green 1 Hyperbaric Oxygenation 1 Drug Therapy 1 Compression Bandages 1 Acupuncture Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04243837 2024-04-23

LYT-100 in Patients With BCRL

PureTech

Phase 2 Terminated

50 enrolled 9 charts

Lymphedema

Data powered by HemOnc (CC BY 4.0) Colophon ⚡